{"id":1758,"date":"2017-01-30T16:54:13","date_gmt":"2017-01-30T21:54:13","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1758"},"modified":"2017-01-30T17:38:12","modified_gmt":"2017-01-30T22:38:12","slug":"13017-secondary-announcement-p-m","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/13017-secondary-announcement-p-m\/","title":{"rendered":"1\/30\/17 Secondary Announcement-P.M."},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating.<\/p>\n<p>Company: Rigel Pharmaceuticals<br \/>\nSymbol: RIGL<br \/>\nPrice: Last trade $2.08<br \/>\nDescription: Re-offer $2.00<br \/>\nTrade Date: 1\/31<br \/>\nShares: 17.5 million<br \/>\nUnderwriter(s)Jefferies, Piper Jaffray, BMO Capital Markets<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Taylor Morrison<br \/>\nSymbol: TMHC<br \/>\nPrice: Last trade $20.96<br \/>\nTrade Date: 2\/1<br \/>\nShares: 10 million<br \/>\nUnderwriter(s)J.P. Morgan, Citigroup, Credit Suisse, Deutsche Bank Securities, BofA Merrill Lynch, Goldman Sachs, Wells Fargo Securities, Zelman Partners LLC<br \/>\nCo Manager(s)HSBC Securities, TPG Capital BD, LLC, Comerica Securities<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Summit Midstream Partners, LP-BLOCK<br \/>\nSymbol: SMLP<br \/>\nPrice: Last trade $26.15<br \/>\nDescription: Re-offer range $24.00-$25.00<br \/>\nTrade Date: 1\/31<br \/>\nShares: 4 million<br \/>\nUnderwriter(s)Barclays<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: First Hawaiian Bank<br \/>\nSymbol: FHB<br \/>\nPrice: Last Trade $32.98<br \/>\nTrade Date: 2\/1<br \/>\nShares: 25 million<br \/>\nUnderwriter(s) Goldman, Sachs &amp; Co., BofA Merrill Lynch, J.P. Morgan, BNP Paribas, Barclays, Citigroup, Credit Suisse, Deutsche Bank Securities<br \/>\nCo-Managers: Keefe Bruyette &amp; Woods<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Rigel Pharmaceuticals Symbol: RIGL Price: Last trade $2.08 Description: Re-offer $2.00 Trade Date: 1\/31 Shares: 17.5 million Underwriter(s)Jefferies, Piper Jaffray, BMO[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[1048,384,1049],"class_list":["post-1758","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-rigl","tag-smlp","tag-tmhc"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1758"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1758\/revisions"}],"predecessor-version":[{"id":1760,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1758\/revisions\/1760"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1758"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1758"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}